Institution
Churchill Hospital
Healthcare•Oxford, United Kingdom•
About: Churchill Hospital is a healthcare organization based out in Oxford, United Kingdom. It is known for research contribution in the topics: Population & Transplantation. The organization has 3548 authors who have published 5357 publications receiving 304275 citations.
Topics: Population, Transplantation, Cancer, Diabetes mellitus, Type 2 diabetes
Papers published on a yearly basis
Papers
More filters
••
TL;DR: British Association of Dermatologists’ guidelines for the management of bullous pemphigoid 2012 V.A.
Abstract: British Association of Dermatologists’ guidelines for the management of bullous pemphigoid 2012 V.A. Venning, K. Taghipour, M.F. Mohd Mustapa, A.S. Highet and G. Kirtschig Department of Dermatology, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, U.K. Department of Dermatology, Whittington Hospital, Magdala Avenue, London N19 5NF, U.K. British Association of Dermatologists, Willan House, 4 Fitzroy Square, London W1T 5HQ, U.K. York Hospital, Wigginton Road, York YO31 8HE, U.K. Vrije Universtiteit, PO Box 7057, Amsterdam NL-1007 MB, the Netherlands
133 citations
••
TL;DR: In this article, the authors compared the efficacy of different fractionation schedules for localised bone metastases achieved by radiotherapy and radioisotopes for more generalised metastatic disease.
Abstract: Background
Radiotherapy is used commonly to provide pain relief for painful bone metastases, and there is a perception that of the three-quarters of patients who achieve pain relief, half of these stay free from pain. However, the precise contribution from radiotherapy may be unclear because of difficulties in assessing the numbers of people achieving relief, the extent of relief and its duration, and the influence of other contemporaneous interventions, such as analgesics.
Objectives
To assess pain relief from:
1. localised bone metastases achieved by radiotherapy, comparing the efficacy of different fractionation schedules
2. more generalised metastatic disease achieved by radiotherapy or radioisotopes.
Search methods
Studies were identified by searching Medline (1966 to August 1998), Embase (1980 to 1998), the Cochrane Library (1998 Issue 3) and the Oxford Pain Relief Database (1950 to 1994).
Selection criteria
The inclusion criteria used were: full journal publication, patients with pain due to bone metastases, and random allocation to a radiotherapeutic intervention (either external irradiation or administration of radioisotopes).
Data collection and analysis
The number of patients achieving complete pain relief and at least 50% at one month were compared with an assumed natural history of 1 in 100 patients achieving pain relief without treatment to obtain the number-needed-to-treat (NNT).
Summed pain relief or pain intensity difference over four to six hours was extracted, converted into dichotomous information yielding the number of patients with at least 50% pain relief, and used to calculate the relative benefit and the NNT for one patient to achieve at least 50% pain relief.
Main results
Twenty trials reported on 43 different radiotherapy fractionation schedules and eight studies of radioisotopes.
Radiotherapy produced complete pain relief at one month in 395/1580 (25%) patients, and at least 50% relief in 788/1933 (41%) patients at some time during the trials. There were no differences in the proportions of patients achieving these outcomes between single or multiple fraction schedules. The number-needed-to-treat (NNT) to achieve complete relief at one month (compared with an assumed natural history of 1 in 100 patients whose pain resolved without treatment) was 4.2 (95% CI 3.7-4.7).
No pooled estimates of speed of onset of relief, or of its duration, could be obtained. In the largest trial (759 patients) 52% of those who had complete relief had achieved it within four weeks, and the median duration of complete relief was 12 weeks.
For more generalised disease, radioisotopes produced similar analgesic results to external irradiation.
Adverse effect reporting was poor. There were no obvious differences between the various fractionation schedules in the incidence of nausea and vomiting, diarrhoea or pathological fractures.
Authors' conclusions
Radiotherapy is clearly effective at reducing pain from painful bone metastases. There was no evidence of any difference in efficacy between different fractionation schedules, nor indeed of a dose-response with total dose of radiation. For treatment of generalised bone pain both hemibody irradiation and radioisotopes can reduce the number of painful new sites.
133 citations
••
TL;DR: The objective of this guideline is to inform individuals making choices about the treatment and management of VWD including the use of therapeutic products.
Abstract: von Willebrand disease (VWD) is the commonest inherited bleeding disorder. The aim of therapy for VWD is to correct the two defects of haemostasis in this disorder, impaired primary haemostasis because of defective platelet adhesion and aggregation and impaired coagulation as a result of low levels of factor VIII. The objective of this guideline is to inform individuals making choices about the treatment and management of VWD including the use of therapeutic products. This is the second edition of this UK Haemophilia Centre Doctors' Organization (UKHCDO) guideline and supersedes the previous edition which was published in 1994.
133 citations
••
University of Texas Health Science Center at Houston1, Tufts University2, Harokopio University3, University of Washington4, Université de Sherbrooke5, Boston University6, Lund University7, Washington University in St. Louis8, National Institutes of Health9, Wake Forest University10, Veterans Health Administration11, Harvard University12, Churchill Hospital13, University of Oxford14, Umeå University15, Uppsala University16, Cedars-Sinai Medical Center17, University of Minnesota18, Karolinska Institutet19
TL;DR: The results support the favorable association of whole- grain intake with fasting glucose and insulin and suggest a potential interaction between variation in GCKR and whole-grain intake in influencing fasting insulin concentrations.
Abstract: OBJECTIVE: Whole-grain foods are touted for multiple health benefits, including enhancing insulin sensitivity and reducing type 2 diabetes risk. Recent genome-wide association studies (GWAS) have identified several single nucleotide polymorphisms (SNPs) associated with fasting glucose and insulin concentrations in individuals free of diabetes. We tested the hypothesis that whole-grain food intake and genetic variation interact to influence concentrations of fasting glucose and insulin. RESEARCH DESIGN AND METHODS: Via meta-analysis of data from 14 cohorts comprising ∼ 48,000 participants of European descent, we studied interactions of whole-grain intake with loci previously associated in GWAS with fasting glucose (16 loci) and/or insulin (2 loci) concentrations. For tests of interaction, we considered a P value <0.0028 (0.05 of 18 tests) as statistically significant. RESULTS: Greater whole-grain food intake was associated with lower fasting glucose and insulin concentrations independent of demographics, other dietary and lifestyle factors, and BMI (β [95% CI] per 1-serving-greater whole-grain intake: -0.009 mmol/l glucose [-0.013 to -0.005], P < 0.0001 and -0.011 pmol/l [ln] insulin [-0.015 to -0.007], P = 0.0003). No interactions met our multiple testing-adjusted statistical significance threshold. The strongest SNP interaction with whole-grain intake was rs780094 (GCKR) for fasting insulin (P = 0.006), where greater whole-grain intake was associated with a smaller reduction in fasting insulin concentrations in those with the insulin-raising allele. CONCLUSIONS: Our results support the favorable association of whole-grain intake with fasting glucose and insulin and suggest a potential interaction between variation in GCKR and whole-grain intake in influencing fasting insulin concentrations.
133 citations
University of California, San Francisco1, Columbia University2, Martin Luther University of Halle-Wittenberg3, McMaster University4, Indiana University5, Catholic University of the Sacred Heart6, University Center of Belo Horizonte7, Churchill Hospital8, University of Chicago9, Katholieke Universiteit Leuven10
TL;DR: In this article, the authors summarized the results of the findings and recommendations of the Working Group on Presentation of Hypoparathyroidism (WGHP) workshop in 2015 and evaluated the literature and recent data on the presentation and long-term outcomes of patients with hypoarthritis.
Abstract: Context: Understanding the etiology, diagnosis, and symptoms of hypoparathyroidism may help to improve quality of life and long-term disease outcomes. This paper summarizes the results of the findings and recommendations of the Working Group on Presentation of Hypoparathyroidism. Evidence Acquisition: Experts convened in Florence, Italy, in May 2015 and evaluated the literature and recent data on the presentation and long-term outcomes of patients with hypoparathyroidism. Evidence Synthesis: The most frequent etiology is surgical removal or loss of viability of parathyroid glands. Despite precautions and expertise, about 20–30% of patients develop transient and 1–7% develop permanent postsurgical hypoparathyroidism after total thyroidectomy. Autoimmune destruction is the main reason for nonsurgical hypoparathyroidism. Severe magnesium deficiency is an uncommon but correctable cause of hypoparathyroidism. Several genetic etiologies can result in the loss of parathyroid function or action causing isolated h...
133 citations
Authors
Showing all 3565 results
Name | H-index | Papers | Citations |
---|---|---|---|
Mark I. McCarthy | 200 | 1028 | 187898 |
Adrian L. Harris | 170 | 1084 | 120365 |
Nicholas J. White | 161 | 1352 | 104539 |
Andrew T. Hattersley | 146 | 768 | 106949 |
Paul Harrison | 133 | 1400 | 80539 |
John F. Thompson | 132 | 1420 | 95894 |
Thomas N. Williams | 132 | 1145 | 95109 |
Kevin Marsh | 128 | 567 | 55356 |
Mark Sullivan | 126 | 802 | 63916 |
Adrian V. S. Hill | 122 | 589 | 64613 |
Ian Tomlinson | 119 | 607 | 55576 |
Richard J.H. Smith | 118 | 1308 | 61779 |
Angela Vincent | 116 | 843 | 52784 |
Cecilia M. Lindgren | 115 | 368 | 89219 |
François Nosten | 114 | 777 | 50823 |